Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 2/2023

Open Access 16-08-2023 | COVID-19 | Review

SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus

Authors: Kyriaki Karavanaki, Spyridon Karanasios, Alexandra Soldatou, Maria Tsolia

Published in: Endocrine | Issue 2/2023

Login to get access

Abstract

Adults with Diabetes Mellitus (DM) have increased risk of severe clinical presentation during COVID-19 infection, while children and adolescents with type 1 diabetes (T1D) have the same mild clinical course as their healthy peers, especially those with optimal glycemic control. The present review focuses on the necessity of COVID-19 vaccination among children and adolescents with T1D, and also in their non-diabetic peers. The efficacy and safety of COVID-19 vaccines are also discussed, as well as their various side-effects, ranging from common mild to very rare and serious ones. Furthermore, the results of COVID-19 vaccination of adolescents with and without T1D are reported, as well as the efficacy and concerns about childhood vaccination. It is concluded that patients with DM of all age groups should maintain optimal diabetic control in order to avoid glycemic deterioration during COVID-19 infection. Furthermore, despite the very rare and serious complications of COVID-19 vaccines, vaccination against COVID-19 is recommended for children and adolescents with T1D to prevent glycemic deterioration and rare but serious complications of COVID-19 infection.
Literature
1.
2.
3.
4.
5.
6.
C.T. Wu, P.V. Lidsky, Y. Xiao, I.T. Lee, R. Cheng, T. Nakayama, S. Jiang, J. Demeter, R.J. Bevacqua, C.A. Chang, R.L. Whitener, A.K. Stalder, B. Zhu, H. Chen, Y. Goltsev, A. Tzankov, J.V. Nayak, G.P. Nolan, M.S. Matter, R. Andino, P.K. Jackson, SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Cell Metab. 33(8 Aug), 1565–1576.e5 (2021). https://​doi.​org/​10.​1016/​j.​cmet.​2021.​05.​013. Epub 2021 May 18. PMID: 34081912; PMCID: PMC8130512CrossRefPubMedPubMedCentral
7.
8.
9.
R. Cardona-Hernandez, V. Cherubini, D. Iafusco, R. Schiaffini, X. Luo, D.M. Maahs, Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr. Diabetes 22(2 Mar), 202–206 (2021). https://​doi.​org/​10.​1111/​pedi.​13158. Epub 2020 Nov 26. PMID: 33205546; PMCID: PMC7753354CrossRefPubMed
10.
11.
12.
13.
14.
M. Stein, L. Ashkenazi-Hoffnung, D. Greenberg, I. Dalal, G. Livni, G. Chapnick, C. Stein-Zamir, S. Ashkenazi, L. Hecht-Sagie, Z. Grossman, The burden of COVID-19 in children and its prevention by vaccination: a joint statement of the Israeli Pediatric Association and the Israeli Society for Pediatric Infectious Diseases. Vaccines (Basel) 10(1 Jan), 81 (2022). https://​doi.​org/​10.​3390/​vaccines10010081​. PMID: 35062742; PMCID: PMC8781684CrossRefPubMed
15.
16.
I. Rabbone, R. Schiaffini, V. Cherubini, C. Maffeis, A. Scaramuzza; Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes, Has COVID-19 delayed the diagnosis and worsened the presentation of Type 1 diabetes in children? Diabetes Care 43(11 Nov), 2870–2872 (2020). https://​doi.​org/​10.​2337/​dc20-1321. Epub 2020 Aug 10. PMID: 32778554CrossRefPubMed
17.
18.
19.
G.T. Alonso, O. Ebekozien, M.P. Gallagher, S. Rompicherla, S.K. Lyons, A. Choudhary, S. Majidi, C.T. Pinnaro, S. Balachandar, M. Gangat, A.J. Curda Roberts, B.E. Marks, A. Creo, J. Sanchez, T. Seeherunvong, J. Jimenez-Vega, N.S. Patel, J.R. Wood, L. Gabriel, K.M. Sumpter, M. Wilkes, R. Rapaport, A. Cymbaluk, J.C. Wong, S. Sanda, A. Albanese-O'neill, Diabetic ketoacidosis drives COVID-19 related hospitalizations in children with type 1 diabetes. J. Diabetes 13(8 Aug), 681–687 (2021). https://​doi.​org/​10.​1111/​1753-0407.​13184. Epub 2021 Apr 27. PMID: 33855813; PMCID: PMC8251108CrossRefPubMed
20.
21.
D. Al-Abdulrazzaq, A. Alkandari, F. Alhusaini, N. Alenazi, U.P. Gujral, K.M.V. Narayan, H. Al-Kandari; CODeR group, Higher rates of diabetic ketoacidosis and admission to the paediatric intensive care unit among newly diagnosed children with type 1 diabetes in Kuwait during the COVID-19 pandemic. Diabetes Metab. Res. Rev. 38(3 Mar), e3506 (2022). https://​doi.​org/​10.​1002/​dmrr.​3506. Epub 2021 Oct 25. PMID: 34679258; PMCID: PMC8646429CrossRefPubMed
22.
23.
S.M. McGlacken-Byrne, S.E.V. Drew, K. Turner, C. Peters, R. Amin, The SARS-CoV-2 pandemic is associated with increased severity of presentation of childhood onset type 1 diabetes mellitus: a multi-centre study of the first COVID-19 wave. Diabet. Med. 38(9 Sep), e14640 (2021). https://​doi.​org/​10.​1111/​dme.​14640. Epub 2021 Jul 18. PMID: 34245598; PMCID: PMC8420510CrossRefPubMedPubMedCentral
24.
25.
R. Unsworth, S. Wallace, N.S. Oliver, S. Yeung, A. Kshirsagar, H. Naidu, R.M.W. Kwong, P. Kumar, K.M. Logan, New-onset Type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 43(11 Nov), e170–e171 (2020). https://​doi.​org/​10.​2337/​dc20-1551. Epub 2020 Aug 17. PMID: 32816997CrossRefPubMed
26.
L. Montefusco, M. Ben Nasr, F. D'Addio, C. Loretelli, A. Rossi, I. Pastore, G. Daniele, A. Abdelsalam, A. Maestroni, M. Dell'Acqua, E. Ippolito, E. Assi, V. Usuelli, A.J. Seelam, R.M. Fiorina, E. Chebat, P. Morpurgo, M.E. Lunati, A.M. Bolla, G. Finzi, R. Abdi, J.V. Bonventre, S. Rusconi, A. Riva, D. Corradi, P. Santus, M. Nebuloni, F. Folli, G.V. Zuccotti, M. Galli, P. Fiorina, Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 3(6), 774–785 (2021). https://​doi.​org/​10.​1038/​s42255-021-00407-6. Epub 2021 May 25CrossRefPubMedPubMedCentral
27.
F. D'Addio, G. Sabiu, V. Usuelli, E. Assi, A. Abdelsalam, A. Maestroni, A.J. Seelam, M. Ben Nasr, C. Loretelli, D. Mileto, G. Rossi, I. Pastore, L. Montefusco, P.S. Morpurgo, L. Plebani, A. Rossi, E. Chebat, A.M. Bolla, M.E. Lunati, C. Mameli, M. Macedoni, S. Antinori, S. Rusconi, M. Gallieni, C. Berra, F. Folli, M. Galli, M.R. Gismondo, G. Zuccotti, P. Fiorina, Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients With Type 1 diabetes. Diabetes 71(8), 1800–1806 (2022). https://​doi.​org/​10.​2337/​db22-0053CrossRefPubMed
28.
K.R. Woodworth, D. Moulia, J.P. Collins, S.C. Hadler, J.M. Jones, S.C. Reddy, M. Chamberland, D. Campos-Outcalt, R.L. Morgan, O. Brooks, H.K. Talbot, G.M. Lee, B.P. Bell, M.F. Daley, S. Mbaeyi, K. Dooling, S.E. Oliver, The advisory committee on immunization practices' interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in children aged 5–11 years - United States, November 2021. MMWR Morb. Mortal. Wkly. Rep. 70(45 Nov), 1579–1583 (2021). https://​doi.​org/​10.​15585/​mmwr.​mm7045e1. PMID: 34758012; PMCID: PMC8580204CrossRefPubMedPubMedCentral
29.
30.
N. Eibl, M. Spatz, G.F. Fischer et al. Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study. Clin. Immunol. 103, 249–259 (2002)CrossRefPubMed
31.
M. Spatz, N. Eibl, S. Hink et al. Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells. Cell. Immunol. 221, 15–26 (2003)CrossRefPubMed
32.
C. Loretelli, A. Abdelsalam, F. D’Addio, M. Ben Nasr, E. Assi, V. Usuelli, A. Maestroni, A.J. Seelam, E. Ippolito, S. Di Maggio, L. Loreggian, D. Radovanovic, C. Vanetti, J. Yang, B. El Essawy, A. Rossi, I. Pastore, L. Montefusco, M.E. Lunati, A.M. Bolla, M. Biasin, S. Antinori, P. Santus, A. Riva, G.V. Zuccotti, M. Galli, S. Rusconi, P. Fiorina, PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response. JCI Insight 6(24 Dec), e146701 (2021). https://​doi.​org/​10.​1172/​jci.​insight.​146701CrossRefPubMedPubMedCentral
33.
34.
35.
36.
R. Marfella, N. D'Onofrio, C. Sardu, L. Scisciola, P. Maggi, N. Coppola, C. Romano, V. Messina, F. Turriziani, M. Siniscalchi, M. Maniscalco, M. Boccalatte, G. Napolitano, L. Salemme, L.V. Marfella, E. Basile, M.V. Montemurro, C. Papa, F. Frascaria, A. Papa, F. Russo, V. Tirino, G. Papaccio, M. Galdiero, F.C. Sasso, M. Barbieri, M.R. Rizzo, M.L. Balestrieri, I.F. Angelillo, C. Napoli, G. Paolisso, Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: the CAVEAT study. Diabetes Obes. Metab. 24(1 Jan), 160–165 (2022). https://​doi.​org/​10.​1111/​dom.​14547. Epub 2021 Oct 1. PMID: 34494705; PMCID: PMC8653151CrossRefPubMed
37.
R.W. Frenck Jr, N.P. Klein, N. Kitchin, A. Gurtman, J. Absalon, S. Lockhart, J.L. Perez, E.B. Walter, S. Senders, R. Bailey, K.A. Swanson, H. Ma, X. Xu, K. Koury, W.V. Kalina, D. Cooper, T. Jennings, D.M. Brandon, S.J. Thomas, Ö. Türeci, D.B. Tresnan, S. Mather, P.R. Dormitzer, U. Şahin, K.U. Jansen, W.C. Gruber, C4591001 Clinical trial group. Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N. Engl. J. Med. 385(3 Jul), 239–250 (2021). https://​doi.​org/​10.​1056/​NEJMoa2107456. Epub 2021 May 27. PMID: 34043894; PMCID: PMC8174030CrossRefPubMed
38.
S.W. Lee, H. Lee, S.K. Lee, J.Y. Moon, S. Moon, S.J. Chung, Y. Yeo, T.S. Park, D. Won Park, T.H. Kim, J.W. Sohn, H.J. Yoon, S.H. Kim, Risk Factors for Grade 3 to Grade 4 Adverse Reactions to the ChAdOx1 nCoV-19 Vaccine (AZD1222) Against SARS-CoV-2. Front. Med. (Lausanne) 8(Sep), 738049 (2021). https://​doi.​org/​10.​3389/​fmed.​2021.​738049. PMID: 34660644; PMCID: PMC8514770CrossRefPubMed
39.
40.
41.
M.E. Oster, D.K. Shay, J.R. Su, J. Gee, C.B. Creech, K.R. Broder, K. Edwards, J.H. Soslow, J.M. Dendy, E. Schlaudecker, S.M. Lang, E.D. Barnett, F.L. Ruberg, M.J. Smith, M.J. Campbell, R.D. Lopes, L.S. Sperling, J.A. Baumblatt, D.L. Thompson, P.L. Marquez, P. Strid, J. Woo, R. Pugsley, S. Reagan-Steiner, F. DeStefano, T.T. Shimabukuro, Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA 327(4 Jan), 331–340 (2022). https://​doi.​org/​10.​1001/​jama.​2021.​24110. PMID: 35076665; PMCID: PMC8790664CrossRefPubMedPubMedCentral
42.
43.
D.T. Truong, A. Dionne, J.C. Muniz, K.E. McHugh, M.A. Portman, L.M. Lambert, D. Thacker, M.D. Elias, J.S. Li, O.H. Toro-Salazar, B.R. Anderson, A.M. Atz, C.M. Bohun, M.J. Campbell, M. Chrisant, L. D'Addese, K.B. Dummer, D. Forsha, L.H. Frank, O.H. Frosch, S.K. Gelehrter, T.M. Giglia, C. Hebson, S.S. Jain, P. Johnston, A. Krishnan, K.C. Lombardi, B.W. McCrindle, E.C. Mitchell, K. Miyata, T. Mizzi, R.M. Parker, J.K. Patel, C. Ronai, A.A. Sabati, J. Schauer, S.K. Sexson Tejtel, J.R. Shea, L.S. Shekerdemian, S. Srivastava, J.K. Votava-Smith, S. White, J.W. Newburger, Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: suspected myocarditis after COVID-19 vaccination. Circulation 145(5 Feb), 345–356 (2022). https://​doi.​org/​10.​1161/​CIRCULATIONAHA.​121.​056583. Epub 2021 Dec 6. PMID: 34865500CrossRefPubMed
44.
45.
46.
47.
48.
D.C. Lyden, J. Olszewski, M. Feran, L.P. Job, S.A. Huber, Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am. J. Pathol. 1987;126(3 Mar):432-8. PMID: 3030117; PMCID: PMC1899641
49.
50.
A. Banerji, P.G. Wickner, R. Saff, C.A. Stone Jr, L.B. Robinson, A.A. Long, A.R. Wolfson, P. Williams, D.A. Khan, E. Phillips, K.G. Blumenthal, mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J. Allergy Clin. Immunol. Pract. 9(4 Apr), 1423–1437 (2021). https://​doi.​org/​10.​1016/​j.​jaip.​2020.​12.​047CrossRefPubMed
51.
R.W. Frenck Jr, N.P. Klein, N. Kitchin, A. Gurtman, J. Absalon, S. Lockhart, J.L. Perez, E.B. Walter, S. Senders, R. Bailey, K.A. Swanson, H. Ma, X. Xu, K. Koury, W.V. Kalina, D. Cooper, T. Jennings, D.M. Brandon, S.J. Thomas, Ö. Türeci, D.B. Tresnan, S. Mather, P.R. Dormitzer, U. Şahin, K.U. Jansen, W.C. Gruber; C4591001 Clinical Trial Group, Safety, immunogenicity, and efficacy of the BNT162b2 Covid-19 vaccine in adolescents. N. Engl. J. Med. 385(3 Jul), 239–250 (2021). https://​doi.​org/​10.​1056/​NEJMoa2107456. Epub 2021 May 27. PMID: 34043894; PMCID: PMC8174030CrossRefPubMed
52.
53.
54.
55.
56.
57.
WHO 2022. Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond:1-50. ISBN (WHO) 978-92-4-006445-4 (electronic version)
58.
K. Miliordos, T. Giannouchos, E. Steletou, G. Sanidas, A. Karkania, A. Vervenioti, G. Dimitriou, D. Gkentzi, Parental attitudes towards vaccination against COVID-19 of children 5–11 years old in Greece. J. Eval. Clin. Pract. 28(6 Dec), 943–947 (2022). https://​doi.​org/​10.​1111/​jep.​13701. Epub 2022 May 23. PMID: 35599609; PMCID: PMC9347632CrossRefPubMed
59.
A.T. Al-Rasheedi, M.A. Elmuttalut, R.H. Al-Mithn, G.S. Al-Harbi, G.S. Al-Ghufaili, Y.H. Al-Mohimeed, A.A. Al-Qutaymi, S.A. Al-Arfaj, Factors predicting caregivers' readiness for vaccination of 5-11 years old children against SARS-CoV-2 - Saudi Arabia, 2022. J. Infect. Dev. Ctries. 16(10 Oct), 1533–1541 (2022). https://​doi.​org/​10.​3855/​jidc.​17073. PMID: 36332205CrossRefPubMed
60.
61.
A.E. Scaramuzza, V. Cherubini, R. Schiaffini, I. Rabbone, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetes. A nationwide survey of Italian pediatric diabetologists about COVID-19 vaccination in children and adolescents with type 1 diabetes. Acta Diabetol. 59(8 Aug), 1109–1111 (2022). https://​doi.​org/​10.​1007/​s00592-022-01885-0. Epub 2022 Apr 21. PMID: 35449238; PMCID: PMC9022735CrossRefPubMedPubMedCentral
62.
C.H. Wang, J. Jones, M.E. Hilliard, C. Tully, M. Monaghan, B.E. Marks, T. Hildebrandt, R. Streisand, Correlates and patterns of COVID-19 vaccination intentions among parents of children with Type 1 Diabetes. J. Pediatr. Psychol. 47(8 Aug), 883–891 (2022). https://​doi.​org/​10.​1093/​jpepsy/​jsac048. PMID: 35689648; PMCID: PMC9214142CrossRefPubMed
63.
64.
R.K. Borchering, L.C. Mullany, E. Howerton, M. Chinazzi, C.P. Smith, M. Qin, N.G. Reich, L. Contamin, J. Levander, J. Kerr, J. Espino, H. Hochheiser, K. Lovett, M. Kinsey, K. Tallaksen, S. Wilson, L. Shin, J.C. Lemaitre, J.D. Hulse, J. Kaminsky, E.C. Lee, A.L. Hill, J.T. Davis, K. Mu, X. Xiong, Y. Pastore, A. Piontti, A. Vespignani, A. Srivastava, P. Porebski, S. Venkatramanan, A. Adiga, B. Lewis, B. Klahn, J. Outten, B. Hurt, J. Chen, H. Mortveit, A. Wilson, M. Marathe, S. Hoops, P. Bhattacharya, D. Machi, S. Chen, R. Paul, D. Janies, J.C. Thill, M. Galanti, T. Yamana, S. Pei, J. Shaman, G. España, S. Cavany, S. Moore, A. Perkins, J.M. Healy, R.B. Slayton, M.A. Johansson, M. Biggerstaff, K. Shea, S.A. Truelove, M.C. Runge, C. Viboud, J. Lessler, Impact of SARS-CoV-2 vaccination of children ages 5–11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model study. Lancet Reg. Health Am. 17(Jan), 100398 (2023). https://​doi.​org/​10.​1016/​j.​lana.​2022.​100398. Epub 2022 Nov 22. PMID: 36437905; PMCID: PMC9679449CrossRefPubMed
65.
S.J. McGurnaghan, A. Weir, J. Bishop et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 9, 82–93 (2021). Public Health Scotland COVID-19 Health Protection Study Group; Scottish Diabetes Research Network Epidemiology GroupCrossRefPubMed
66.
67.
Metadata
Title
SARS-CoV-2 vaccination in children and adolescents with and without type 1 diabetes mellitus
Authors
Kyriaki Karavanaki
Spyridon Karanasios
Alexandra Soldatou
Maria Tsolia
Publication date
16-08-2023
Publisher
Springer US
Published in
Endocrine / Issue 2/2023
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03471-y

Other articles of this Issue 2/2023

Endocrine 2/2023 Go to the issue

Original Article

Preference of acromegaly patients for treatment attributes in Spain

Original Article

Utility of histopathological revision in the management of gastro-entero-pancreatic neuroendocrine neoplasia

Original Article

Diagnosis and management of tumor-induced osteomalacia: a single center experience

Original Article

Long-term low-dose tolvaptan efficacy and safety in SIADH

Meta- Analysis

Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study

Original Article

Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits